|
1
|
Wilson RC and Doudna JA: Molecular
mechanisms of RNA interference. Annu Rev Biophys. 42:217–239. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen X, Mangala LS, Rodriguez-Aguayo C,
Kong X, Lopez-Berestein G and Sood AK: RNA interference-based
therapy and its delivery systems. Cancer Metastasis Rev.
37:107–124. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang S, Zhi D and Huang L: Lipid-based
vectors for siRNA delivery. J Drug Target. 20:724–735. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zatsepin TS, Kotelevtsev YV and
Koteliansky V: Lipid nanoparticles for targeted siRNA
delivery-going from bench to bedside. Int J Nanomedicine.
11:3077–3086. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Satterlee A and Huang L: In vivo
gene delivery by nonviral vectors: Overcoming hurdles? Mol Ther.
20:1298–1304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xia Y, Tian J and Chen X: Effect of
surface properties on liposomal siRNA delivery. Biomaterials.
79:56–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hatakeyama H, Akita H and Harashima H: The
polyethyleneglycol dilemma: Advantage and disadvantage of
PEGylation of liposomes for systemic genes and nucleic acids
delivery to tumors. Biol Pharm Bull. 36:892–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hattori Y, Shimizu S, Ozaki KI and Onishi
H: Effect of cationic lipid type in Folate-PEG-modified cationic
liposomes on folate receptor-mediated siRNA transfection in tumor
cells. Pharmaceutics. 11:1812019. View Article : Google Scholar
|
|
9
|
Sonoke S, Ueda T, Fujiwara K, Sato Y,
Takagaki K, Hirabayashi K, Ohgi T and Yano J: Tumor regression in
mice by delivery of Bcl-2 small interfering RNA with pegylated
cationic liposomes. Cancer Res. 68:8843–8851. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song F, Sakurai N, Okamoto A, Koide H, Oku
N, Dewa T and Asai T: Design of a novel PEGylated liposomal vector
for systemic delivery of siRNA to solid tumors. Biol Pharm Bull.
42:996–1003. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen S, Tam YY, Lin PJ, Leung AK, Tam YK
and Cullis PR: Development of lipid nanoparticle formulations of
siRNA for hepatocyte gene silencing following subcutaneous
administration. J Control Release. 196:106–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakamura T, Noma Y, Sakurai Y and
Harashima H: Modifying cationic liposomes with cholesteryl-PEG
prevents their aggregation in human urine and enhances cellular
uptake by bladder cancer cells. Biol Pharm Bull. 40:234–237. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hattori Y, Nakamura T, Ohno H, Fujii N and
Maitani Y: siRNA delivery into tumor cells by lipid-based
nanoparticles composed of hydroxyethylated cholesteryl triamine.
Int J Pharm. 443:221–229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hattori Y, Hara E, Shingu Y, Minamiguchi
D, Nakamura A, Arai S, Ohno H, Kawano K, Fujii N and Yonemochi E:
siRNA delivery into tumor cells by cationic cholesterol
derivative-based nanoparticles and liposomes. Biol Pharm Bull.
38:30–38. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hattori Y, Arai S, Kikuchi T, Ozaki K,
Kawano K and Yonemochi E: Therapeutic effect for liver-metastasized
tumor by sequential intravenous injection of anionic polymer and
cationic lipoplex of siRNA. J Drug Target. 24:309–317. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dawlee S, Sugandhi A, Balakrishnan B,
Labarre D and Jayakrishnan A: Oxidized chondroitin
sulfate-cross-linked gelatin matrixes: A new class of hydrogels.
Biomacromolecules. 6:2040–2048. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sasatsu M, Onishi H and Machida Y:
Preparation of a PLA-PEG block copolymer using a PLA derivative
with a formyl terminal group and its application to nanoparticulate
formulation. Int J Pharm. 294:233–245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hattori Y, Nakamura A, Hanaya S, Miyanabe
Y, Yoshiike Y, Kikuchi T, Ozaki KI and Onishi H: Effect of
chondroitin sulfate on siRNA biodistribution and gene silencing
effect in mice after injection of siRNA lipoplexes. J Drug Deliv
Sci Tech. 41:401–409. 2017. View Article : Google Scholar
|
|
19
|
Hattori Y, Nakamura A, Arai S, Nishigaki
M, Ohkura H, Kawano K, Maitani Y and Yonemochi E: In vivo siRNA
delivery system for targeting to the liver by poly-l-glutamic
acid-coated lipoplex. Results Pharma Sci. 4:1–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hattori Y, Yamasaku H and Maitani Y:
Anionic polymer-coated lipoplex for safe gene delivery into tumor
by systemic injection. J Drug Target. 21:639–647. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang Y, Xue J, Gao S, Lu A, Yang D, Jiang
H, He Y and Shi K: Cleavable PEGylation: A strategy for overcoming
the ‘PEG dilemma’ in efficient drug delivery. Drug Deliv. 24
(sup1):22–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
